SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-252903
Filing Date
2021-08-20
Accepted
2021-08-20 17:20:07
Documents
16
Period of Report
2021-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d190005d8k.htm   iXBRL 8-K 31171
2 EX-1.1 d190005dex11.htm EX-1.1 234737
3 EX-5.1 d190005dex51.htm EX-5.1 9310
7 GRAPHIC g190005sp03.jpg GRAPHIC 11338
8 GRAPHIC g190005sp2.jpg GRAPHIC 5040
  Complete submission text file 0001193125-21-252903.txt   491543

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atnx-20210820.xsd EX-101.SCH 2888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20210820_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20210820_pre.xml EX-101.PRE 11405
9 EXTRACTED XBRL INSTANCE DOCUMENT d190005d8k_htm.xml XML 3344
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38112 | Film No.: 211194666
SIC: 2834 Pharmaceutical Preparations